financetom
Business
financetom
/
Business
/
Roblox Stock Climbs Despite Guidance Reset: What To Know
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Roblox Stock Climbs Despite Guidance Reset: What To Know
May 12, 2026 7:27 AM

Roblox Corp ( RBLX ) shares are climbing higher on Tuesday as traders continue to weigh guidance reset concerns against signs that engagement trends are holding up. Here’s what investors need to know.

Roblox ( RBLX ) stock is surging to new heights today. What’s behind RBLX gains?

What Is Driving Roblox’s Stock Movement?

The latest bounce comes as investors revisit the post-earnings guidance reset, after Roblox ( RBLX ) cut FY2026 adjusted revenue guidance to a $7.33 billion–$7.6 billion range from $8.28 billion–$8.55 billion, while reporting improving usage metrics.

Roblox ( RBLX ) also guided for second-quarter adjusted revenue of $1.55 billion–$1.61 billion versus a $1.83 billion Street consensus, keeping "outlook risk" front-and-center even as usage trends improved in the quarter.

In the same quarterly update, Roblox ( RBLX ) posted a loss of 35 cents on $1.73 billion in revenue, with daily active users up 35% to 132 million, helping keep the debate centered on whether the selloff was more about forward expectations than current platform demand.

Roblox ( RBLX ) posted bookings up 43% year-over-year to $1.7 billion and average monthly unique payers up 52% to 31 million, reinforcing the bull case that monetization is still scaling even after the guide-down. CEO David Baszucki called it "another strong quarter of growth."

Critical Levels To Watch for RBLX Stock

The bigger-picture chart is still in repair mode: the stock is trading 20.2% below its 20-day SMA, 24.6% below its 50-day SMA, 34.8% below its 100-day SMA, and 53.9% below its 200-day SMA. With the 20-day SMA below the 50-day SMA and the death cross that formed in December 2025, rallies tend to be treated as counter-trend until price can reclaim those trend lines.

Momentum is the more actionable part right now, with RSI at 26.87, which is oversold and signals the selling has become stretched. RSI is a simple gauge of how extended the move is, and readings below 30 often line up with conditions where downside pressure can cool if sellers back off.

Key Resistance: $60.00 — a round-number level that lines up with the broader 50-day zone where rebounds often stall in downtrends

Key Support: $42.00 — near the recent low area and close to the bottom of the current 52-week range

How Roblox Operates Its Gaming Platform

Roblox ( RBLX ) operates a free-to-play online video game platform with nearly 150 million daily active users, built around a creator ecosystem and a virtual economy that runs on the Robux currency. The platform hosts millions of games made by creators ranging from kids to professional studios, and Roblox ( RBLX ) provides the tools and distribution that let those experiences reach users.

Creators earn money when users make optional in-game purchases and through real-world advertising, and Roblox ( RBLX ) takes a cut of those transactions. That's why guidance changes can hit the stock hard: expectations for revenue and bookings are tightly tied to engagement, payer growth and how much users spend inside the ecosystem.

Analysts Lower Roblox Stock Price Targets

Analyst Consensus & Recent Actions: The stock carries a Buy rating with an average price target of $79.74. Recent analyst moves include:

Piper Sandler: Downgraded to Neutral (Lowers Target to $50.00) (May 5)

Goldman Sachs: Buy (Lowers Target to $65.00) (May 4)

Citigroup: Buy (Lowers Target to $70.00) (May 4)

Roblox Stock Price Activity on Tuesday

RBLX Stock Price Activity: Roblox ( RBLX ) shares were trading 4.65% higher at $43.23 at the time of publication on Tuesday, according to Benzinga Pro data.

Read Also:

Inflation Jumps To 3.8% In April, Kills Fed Rate-Cut Hopes

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved